Skip to content

The Effect of Chlorhexidine Mouthwash on Postprandial Glucose Response in Healthy Individuals

The Effect of Chlorhexidine Mouthwash on Postprandial Glucose Response in Healthy Individuals

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07172009
Enrollment
45
Registered
2025-09-15
Start date
2022-06-08
Completion date
2026-06-01
Last updated
2025-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glucose Metabolism Disorders (Including Diabetes Mellitus)

Brief summary

The digestion of carbohydrates begins in the mouth through the salivary enzyme amylase which breaks food starches into maltose and disaccharides. The mouth also has a large community of microorganisms which include bacteria, fungi, viruses and protozoa that can also assist in the digestion of carbohydrates. Mouthwashes containing antibacterial compounds such as chlorhexidine are used to kill oral bacteria, but current evidence indicates that a majority of these bacteria are essential for human health. The aim of this study is to investigate whether chlorhexidine mouthwash can also affect the digestion of carbohydrates. At least 25 individuals will be recruited. Participants will visit the laboratory in two occasions. A saliva and blood sample (fingertip to measure blood glucose) will be taken at baseline. Then, using a randomized, cross-over and double-blind design, the participants will rinse their mouth for two minutes with a placebo or chlorhexidine mouthwash. Then, participants will eat 50 g of white bread and blood glucose will be measured (fingertips) every 30 min for the following 2 hours. Another saliva sample will be collected at the end of each test.

Detailed description

Blood glucose is measured at baseline and following food intake using a blood glucose meter (ACCU-CHEK Performa, Roche, USA). Participants are then provided with 10 mL of the assigned mouthwash according to randomisation. Mouthwashes are blinded for both researchers and participants, as they are prepared by an external individual, covered, and labelled with group numbers. This ensures that neither participants nor researchers can identify the treatment allocation. Oral rinsing is performed for 2 minutes before participants spit out the mouthwash. The mouthwashes used include: Chlorhexidine di-gluconate (0.2%) (Corsodyl, GlaxoSmithKline, England) Placebo (water with yellow food colouring) Following the mouth rinse, participants consume a pre-weighed breakfast meal consisting of 40 g of Hubbard's Foodstore® strawberry jam (Sainsbury's Supermarkets Ltd., London, UK) spread over 50 g of soft white bread (Sainsbury's Supermarkets Ltd., Northern Ireland, UK). Blood glucose measurements are taken at 15, 30, 45, 60, 90, and 120 minutes post-meal.Baseline blood glucose values are used as reference points. For analysis, only the differences between baseline and subsequent time-point measurements are considered. The mean iAUC is calculated for each mouthwash condition (chlorhexidine and placebo). Each participant completes the protocol twice, once for each mouthwash condition, with a minimum washout period of 48 hours between sessions.

Interventions

OTHERChlorhexidine mouthwash

Rinsing the mouth with chlorhexidine mouthwash for 2 minutes before consuming 50 g of carbohydrates

OTHERPlacebo mouthwash

Rinsing the mouth with placebo mouthwash for 2 minutes before consuming 50 g of carbohydrates

Sponsors

University of Plymouth
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Healthy adults (\> 18 years/old)

Exclusion criteria

The main

Design outcomes

Primary

MeasureTime frame
Blood glucose2 hours

Countries

United Kingdom

Contacts

Primary ContactRaul Bescos Garcia
Raul.Bescos@plymouth.ac.uk07599034710
Backup ContactZoe Brookes
Zoe.Brookes@plymouth.ac.uk+44 1752 586828

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026